These guys make me laugh. It "looks cheap," hey? This is a company with no compounds in Phase III trials, and a market cap in excess of 400 million (fully diluted).
It "looks overvalued" to me.
AVX Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held